IP Amendments Bill 2013: #2 Proposal for a ‘manufacture for export’ exception to pharmaceutical patent rights in Australia

By

Schedule 2 of the INTELLECTUAL PROPERTY LAWS AMENDMENT BILL 2013 read before the House of Representatives on 30 May 2013 proposes amendments to enable least-developed and developing countries to source generic versions of patented pharmaceutical products from Australia to treat public health crises. In this, the second of 6 posts relating to the proposed changes, …
>> Read more

Australian IP Litigation Round-Up 25 May 2013

By

An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal as of 24 May 2013. We advise our clients (whether as IP owners or as alleged infringers) and act for them in relation to patent litigation, trade mark litigation, registered design litigation, domain name, plant breeder’s rights, confidential information and copyright litigation.  Contact us …
>> Read more

Australian Patent Round-Up 23 May 2013

By

An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 23 May 2013. If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.

BRCA1 & BRCA2 Genetic Testing – What do you get for $3000?

By

With the recent media coverage of Angelina Jolie’s decision to have a preventative double mastectomy following genetic testing for BRCA mutations and with the price of this genetic test (approximately $3000AUD) from Myriad Genetics often being referred to, we were curious as to what is actually involved in the test.